Answer
Renal impairment and symptomatic hypocalcaemia, including Trousseau's and Chvostek's signs, have been observed during concurrent treatment with foscarnet sodium hexahydrate and intravenous pentamidine.
Sources for this answer
- Foscarnet sodium Tillomed 24 mg/ml solution for infusionTillomed Laboratories Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 2Document updated
Sources checked